New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 21, 2012
12:16 EDTBASFY, AMRNBASF acquisition a positive for Amarin, says Leerink
Leerink views BASF's (BASFY) acquisition of Pronova BioPharma a positive for Amarin (AMRN). The firm believes the deal sets a high floor value for Amarin's Vascepa and reiterates an Outperform rating on the stock with a $27 fair value estimate.
News For AMRN;BASFY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
07:35 EDTAMRNCardiometabolic Health Congress to hold annual meeting
Subscribe for More Information
October 20, 2014
11:08 EDTBASFYBASF management to meet with Jefferies
Meeting to be held in Los Angeles/ New Port Beach, CA on October 27 hosted by Jefferies.
October 16, 2014
08:08 EDTAMRNAmarin sees cash and cash equivalents of $135.4M at September 30
Subscribe for More Information
October 15, 2014
10:23 EDTAMRNAmarin management to meet with Oppenheimer
Meeting to be held on the West Coast on October 22 hosted by Oppenheimer.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use